• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma 2023: Vaccines Journey to the Consumer

Article

Stefan Merlo, Vice President, Commercial Development, CSL Seqirus discusses how COVID-19 has evolved the discussion of vaccines and the long-term concerns stemming from flu vaccine fatigue.

At Pharma 2023 in Barcelona, Stefan Merlo, Vice President, Commercial Development at CSL Seqirus, discussed the global vaccine journey, the connected customer experience and the role of consumer and government education to improve public health.

Recent Videos
2023-07-12_Video Teaser_PE Podcast_Reproductive Health_Elizabeth Garner, Chief Scientific Officer, Ferring Pharmaceuticals_Meg Rivers
Related Content
JPM25: Oncology Outlook for 2025

JPM25: Oncology Outlook for 2025

Miranda Schmalfuhs
January 20th 2025
Article

Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.

HHS Selects 15 New Drugs for Medicare Part D Price Negotiations

HHS Selects 15 New Drugs for Medicare Part D Price Negotiations

Don Tracy, Associate Editor
January 17th 2025
Article

As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices expected to take effect in 2027.

Stock.adobe.com

NVIDIA Announces Pharma Partnerships to Expand AI

Mike Hollan
January 15th 2025
Article

The company revealed plans to increase the usage of AI in pharma at JP Morgan’s healthcare conference in San Francisco.

Stock.adobe.com

Moderna Details Product Pipeline and Finances Ahead of JP Morgan Presentation

Mike Hollan
January 14th 2025
Article

Moderna provided updates on key elements of its pipeline, including a next-generation COVID-19 vaccine, an RSV vaccine, a new seasonal flu, and a combination seasonal flu/COVID vaccine.

Stock.adobe.com

Biohaven Details Pipeline Update At JP Morgan Conference

Mike Hollan
January 14th 2025
Article

The company provided information about its upcoming oncology portfolio, along with developments from its MoDE platform.

Flurry of Acquisitions and Licensing Deals Come Amid JP Morgan Healthcare Conference 2025

Flurry of Acquisitions and Licensing Deals Come Amid JP Morgan Healthcare Conference 2025

Don Tracy, Associate Editor
January 13th 2025
Article

Organizations including Gilead, Eli Lilly, and AbbVie announced a number of deals addressing inflammatory diseases, multiple myeloma, and other disease areas.